VNA
RXII

Valley National Advisers’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Valley National Advisers’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,574
Closed -$1K – 807
2016
Q3 		$1K Hold
2,574
– – ﹤0.01% 630
2016
Q2 		$1K Hold
2,574
– – ﹤0.01% 601
2016
Q1 		$4K Hold
2,574
– – ﹤0.01% 481
2015
Q4 		$4K Hold
2,574
– – ﹤0.01% 480
2015
Q3 		$4K Hold
2,574
– – ﹤0.01% 477
2015
Q2 		$4K Hold
2,574
– – ﹤0.01% 482
2015
Q1 		$4K Buy
2,574
+1,574
+157% +$2.45K ﹤0.01% 466
2014
Q4 		$5K Buy
+1,000
New +$5K ﹤0.01% 345

Valley National Advisers's RXII Position: Q4 2016 in Review

Valley National Advisers sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 2,574 shares — an estimated $1K sold.

Valley National Advisers first reported a position in RXII in Q4 2014 and held it in 8 quarters. The position peaked at $5K in Q4 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Valley National Advisers reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Valley National Advisers sold 2,574 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $1K.
  • Valley National Advisers first reported a position in GALENA BIOPHARMA INC COM in Q4 2014 and held it in 8 quarters.
  • Valley National Advisers's GALENA BIOPHARMA INC COM position peaked at $5K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Valley National Advisers's 13F filing for Q4 2016, filed 31 Jan 2017.